-
HEALTHCARE UTILIZATION PATTERNS AMONG MEDICARE BENEFICIARIES WITH FINANCIAL CONSTRAINTS
Mar 18, 2026, 21:38 PM -
IMPUTATION OF LONGITUDINAL OUTCOMES WHEN MISSINGNESS IS NOT AT RANDOM
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF HARTC 2.0 TRIAL: PREHOSPITAL ACS TRIAGE USING A MODIFIED HEART SCORE WITH POINT-OF-CARE HS-CTNI
Mar 18, 2026, 21:38 PM -
ARE WE MAKING THE RIGHT COMPARISONS? EXAMINING THE WILLINGNESS-TO-PAY THRESHOLD UNDER DIFFERENT PERSPECTIVES
Mar 18, 2026, 21:38 PM -
COST EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB? VERSUS CYCLOSPORINE A IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY
Mar 18, 2026, 21:38 PM -
ACCESS TO GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ANTIOBESITY MEDICATIONS: FORMULARY COVERAGE AND PRIOR AUTHORIZATION RESTRICTIONS ACROSS U.S. PAYERS
Mar 18, 2026, 21:38 PM -
SOCIAL DETERMINANTS OF HEALTH ENABLE EARLY IDENTIFICATION OF PREMATURE MORTALITY RISK
Mar 18, 2026, 21:38 PM -
REVIEW OF CEESP ICERS FOR ORPHAN AND NON-ORPHAN TREATMENTS IN FRANCE, 2024 - 2025
Mar 18, 2026, 21:38 PM -
WHAT HEOR CAN LEARN FROM MATURE AI INDUSTRIES AND WHERE THE ANALOGIES BREAK DOWN
Mar 18, 2026, 21:38 PM -
QUANTIFYING CDA-INESSS DIFFERENCES IN ONCOLOGY HTA: RECOMMENDATIONS, RE-ANALYSIS, AND PRICE REDUCTIONS (2024-2025)
Mar 18, 2026, 21:38 PM -
REPORTING AI-ASSISTED METHODS IN PROSPERO-REGISTERED ONCOLOGY SLR PROTOCOLS: TRENDS AND GAPS
Mar 18, 2026, 21:38 PM -
REGULATORY CHALLENGES AND INSIGHTS FROM FDA IN 2025; POTENTIAL IMPLICATIONS OF THE PLAUSIBLE MECHANISM PATHWAY AND SUBSEQUENT HEALTH TECHNOLOGY ASSESSMENTS
Mar 18, 2026, 21:38 PM -
OPIOID TAPERING AND RISK OF CARDIOVASCULAR DISEASES AMONG OLDER ADULTS: A CASE-CROSSOVER STUDY
Mar 18, 2026, 21:38 PM -
A FEDERATED ANALYSIS OF CLINICAL REAL-WORLD DATA LINKING TREATMENT PERSISTENCE AND SOCIO-ECONOMIC OUTCOMES IN MULTIPLE SCLEROSIS ACROSS DIFFERENT HEALTHCARE SYSTEMS
Mar 18, 2026, 21:38 PM -
STUDY ON PHARMACISTS' AWARENESS ON VACCINATION IN PHARMACIES DURING WARTIME IN UKRAINE
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF PATIENTS WITH NAMD OR DME WHO MAY REQUIRE MONTHLY DOSING WITH AFLIBERCEPT 8 MG
Mar 18, 2026, 21:38 PM -
CAN NEIGHBORHOOD-LEVEL SOCIAL DETERMINANTS OF HEALTH MEASURES IMPROVE MACHINE LEARNING CLASSIFICATION TASKS? DETECTING ALCOHOL USE DISORDER AS A USE CASE
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF DPYD-GUIDED FOLFOX IN UNRESECTABLE METASTATIC COLORECTAL CANCER IN THE US: A PATIENT-LEVEL MICROSIMULATION MODEL
Mar 18, 2026, 21:38 PM -
EFFECTIVENESS OF COMMUNITY-BASED AND HOME-BASED HEALTH INTERVENTIONS FOR HEALTHY AGING IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS
Mar 18, 2026, 21:38 PM -
ONE GLOBAL EVIDENCE PLAN FOR MANY DECISION-MAKERS: ALIGNING EVIDENCE FOR EU JCA, AMCP DOSSIER, AND ICER REVIEWS
Mar 18, 2026, 21:38 PM
